Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies
- PMID: 23280628
- PMCID: PMC3670948
- DOI: 10.1002/gepi.21707
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies
Abstract
Genomewide association studies (GWAS) and candidate-gene studies have implicated single-nucleotide polymorphisms (SNPs) in at least 45 different genes as putative glioma risk factors. Attempts to validate these associations have yielded variable results and few genetic risk factors have been consistently replicated. We conducted a case-control study of Caucasian glioma cases and controls from the University of California San Francisco (810 cases, 512 controls) and the Mayo Clinic (852 cases, 789 controls) in an attempt to replicate previously reported genetic risk factors for glioma. Sixty SNPs selected from the literature (eight from GWAS and 52 from candidate-gene studies) were successfully genotyped on an Illumina custom genotyping panel. Eight SNPs in/near seven different genes (TERT, EGFR, CCDC26, CDKN2A, PHLDB1, RTEL1, TP53) were significantly associated with glioma risk in the combined dataset (P < 0.05), with all associations in the same direction as in previous reports. Several SNP associations showed considerable differences across histologic subtype. All eight successfully replicated associations were first identified by GWAS, although none of the putative risk SNPs from candidate-gene studies was associated in the full case-control sample (all P values > 0.05). Although several confirmed associations are located near genes long known to be involved in gliomagenesis (e.g., EGFR, CDKN2A, TP53), these associations were first discovered by the GWAS approach and are in noncoding regions. These results highlight that the deficiencies of the candidate-gene approach lay in selecting both appropriate genes and relevant SNPs within these genes.
© 2012 WILEY PERIODICALS, INC.
Conflict of interest statement
The authors do not have any conflicts of interest, financial or otherwise.
Similar articles
-
Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.Mol Biol Rep. 2020 Feb;47(2):877-886. doi: 10.1007/s11033-019-05178-8. Epub 2019 Nov 12. Mol Biol Rep. 2020. PMID: 31721021
-
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.Neuro Oncol. 2013 Aug;15(8):1041-7. doi: 10.1093/neuonc/not051. Epub 2013 Jun 3. Neuro Oncol. 2013. PMID: 23733245 Free PMC article.
-
CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.Carcinogenesis. 2015 Aug;36(8):876-82. doi: 10.1093/carcin/bgv074. Epub 2015 May 25. Carcinogenesis. 2015. PMID: 26014354
-
Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis.Biochem Genet. 2019 Aug;57(4):583-605. doi: 10.1007/s10528-019-09911-7. Epub 2019 Feb 18. Biochem Genet. 2019. PMID: 30778791
-
A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk.J Neurooncol. 2013 Feb;111(3):221-8. doi: 10.1007/s11060-012-1022-1. Epub 2012 Dec 13. J Neurooncol. 2013. PMID: 23238971 Review.
Cited by
-
Genome-Wide Association Studies in Glioma.Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):418-428. doi: 10.1158/1055-9965.EPI-17-1080. Epub 2018 Jan 30. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29382702 Free PMC article. Review.
-
An integrated genome and phenome-wide association study approach to understanding Alzheimer's disease predisposition.Neurobiol Aging. 2022 Oct;118:117-123. doi: 10.1016/j.neurobiolaging.2022.05.011. Epub 2022 May 27. Neurobiol Aging. 2022. PMID: 35715361 Free PMC article.
-
Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis.Tumour Biol. 2015 Jan;36(1):121-7. doi: 10.1007/s13277-014-2895-8. Epub 2014 Dec 4. Tumour Biol. 2015. PMID: 25472582
-
The Fourth Law of Behavior Genetics.Curr Dir Psychol Sci. 2015 Jul 1;24(4):304-312. doi: 10.1177/0963721415580430. Curr Dir Psychol Sci. 2015. PMID: 26556960 Free PMC article.
-
Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.Hum Mutat. 2015 Jul;36(7):684-8. doi: 10.1002/humu.22799. Epub 2015 May 18. Hum Mutat. 2015. PMID: 25907361 Free PMC article.
References
-
- Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, et al. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev. 2008a;17(4):987–989. - PubMed
-
- Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, et al. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008b;17(5):1195–1202. - PubMed
-
- Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet. 2008c;17(6):800–805. - PubMed
-
- Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis. 2007;28(12):2543–2547. - PubMed
-
- Caggana M, Kilgallen J, Conroy JM, Wiencke JK, Kelsey KT, Miike R, Chen P, Wrensch MR. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev. 2001;10(4):355–360. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 CA108961/CA/NCI NIH HHS/United States
- RC1 NS068222/NS/NINDS NIH HHS/United States
- RC1NS068222Z/NS/NINDS NIH HHS/United States
- R25 CA112355/CA/NCI NIH HHS/United States
- HHSN261201000036C/CA/NCI NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- 1U58 DP000807-01/DP/NCCDPHP CDC HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- R01CA52689/CA/NCI NIH HHS/United States
- P30 CA15083/CA/NCI NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- R25CA112355/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- P50CA097257/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- P50CA108961/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous